Skip to main content
SpringerLink
Log in

Lokale Therapie von Plattenepithelkarzinomen

Topical therapy of squamous cell carcinoma

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Eine Vielzahl lokaler Formen der Chemo- bzw. Immuntherapie wird in der Dermatologie zur Behandlung von Hautkrebs angewendet. Speziell für die verschiedenen Formen des nichtmelanozytären Hautkrebses (NMSC) in Form flächenhafter, sog. „Krebsfelder“ („field cancerization“) sind topische Therapien besonders hilfreich. Es obliegt dem Dermatologen, die adäquaten Patienten und NMSC-Läsionen den entsprechend geeigneten Therapien zuzuführen.

Abstract

Many forms of topical chemo- and immunotherapy are employed to treat skin cancers. Topical treatment is particularly attractive for field cancerization involving multiple non-melanoma skin cancers. The dermatologist must identify such patients and lesions and provide the most suited therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Abdullah AN, Walzman M, Wade A (1993) Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloroacetic acid. Sex Transm Dis 20: 344–345

    PubMed  Google Scholar 

  2. Akar A, Bulent Tastan H, Erbil H, Arca E, Kurumlu Z, Gur AR (2001) Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses. J Dermatolog Treat 12: 199–203

    Article  PubMed  Google Scholar 

  3. Alexiades-Armenakas MR, Geronemus RG (2003) Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 139: 1313–1320

    Article  PubMed  Google Scholar 

  4. Alirezai M, Dupuy P, Amblard P, Kalis B et al. (1994) Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 30: 447–451

    PubMed  Google Scholar 

  5. Avril MF, Auperin A, Margulis A et al. (1997) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76: 100–106

    PubMed  Google Scholar 

  6. Basset-Seguin N, Ibbotson S, Emtestam L et al. (2004) MAL-PDT vs. cryotherapy in primary sBCC: results of 36-month follow up. J Eur Acad Dermatol Venereol 18: S412

    Google Scholar 

  7. Bath-Hextall FJ, Perkins W, Bong J, Williams HC (2007) Interventions for basal cell carcinoma of the skin. The Cochrane Database of Systematic Reviews 2007, Issue 1

  8. Ben-Chetrit E, Levy M (1998) Colchicine: 1998 update. Semin Arthritis Rheum 28: 48–59

    Article  PubMed  Google Scholar 

  9. Beutner KR, Geisse JK, Helman D et al. (1999) Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 41: 1002–1007

    Article  PubMed  Google Scholar 

  10. Bianchi L, Orlandi A, Campione E et al. (2004) Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol 151: 148–156

    Article  PubMed  Google Scholar 

  11. Braathen LR, Szeimies RM, Basset-Seguin N et al. (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56: 125–143

    Article  PubMed  Google Scholar 

  12. Falagas ME, Angelousi AG, Peppas G (2006) Imiquimod for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials. J Am Acad Dermatol 55: 537–538

    Article  PubMed  Google Scholar 

  13. Fariba I, Ali A, Hossein SA et al. (2006) Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study. Indian J Dermatol Venereol Leprol 72: 346–349

    PubMed  Google Scholar 

  14. Foley P (2003) Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat 14: 15–22

    PubMed  Google Scholar 

  15. Freeman M, Vinciullo C, Francis D et al. (2003) A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 14: 99–106

    Article  PubMed  Google Scholar 

  16. Geisse J, Caro I, Lindholm J et al. (2004) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50: 722–733

    Article  PubMed  Google Scholar 

  17. Godley MJ, Bradbeer CS, Gellan M, Thin RN (1987) Cryotherapy compared with trichloroacetic acid in treating genital warts. Genitourin Med 63: 390–392

    PubMed  Google Scholar 

  18. Goette DK, Odom RB, Arrott JW et al. (1982) Treatment of keratoacanthoma with topical application of fluorouracil. Arch Dermatol 118: 309–311

    Article  PubMed  Google Scholar 

  19. Gollnick H, Barona CG, Frank RG et al. (2005) Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 15: 374–381

    PubMed  Google Scholar 

  20. Grimaitre M, Etienne A, Fathi M et al. (2000) Topical colchicine therapy for actinic keratoses. Dermatology 200: 346–348

    Article  PubMed  Google Scholar 

  21. Hadley G, Derry S, Moore RA (2006) Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol 126: 1251–1255

    Article  PubMed  Google Scholar 

  22. Hall VL, Leppard BJ, McGill J et al. (1986) Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 37: 33–34

    Article  PubMed  Google Scholar 

  23. Hazard K, Karlsson A, Andersson K et al. (2007) Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 127: 116–119

    Article  PubMed  Google Scholar 

  24. Hengge UR, Stark R (2001) Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 137: 709–711

    PubMed  Google Scholar 

  25. Hundeiker M, Sebastian G, Bassukas ID et al. (2005) Cryotherapy in dermatology. J Dtsch Dermatol Ges 3: 1009–1015

    Article  PubMed  Google Scholar 

  26. Jorizzo J, Weiss J, Furst K et al. (2004) Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Arch Dermatol 140: 813–816

    Article  PubMed  Google Scholar 

  27. Jury CS, Ramraka-Jones VS, Gudi V, Herd RM (2005) A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment. Br J Dermatol 153: 808–810

    Article  PubMed  Google Scholar 

  28. Kligman AL, Thorne EG (1991) Topical therapy of actinic keratoses with tretinoin. In: Marks R (ed.) Retinods in cutaneous malignancy. Blackwell Scientific Publications, Oxford, pp 66–73

  29. Labandeira J, Pereiro M Jr, Valdes F, Toribio J (2004) Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Dermatol Surg 30: 517–520

    Article  PubMed  Google Scholar 

  30. Lawrence N, Cox SE, Cockerell CJ et al. (1995) A comparison of the efficacy and safety of Jessner’s solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 131: 176–181

    Article  PubMed  Google Scholar 

  31. Loven K, Stein L, Furst K, Levy S (2002) Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 24: 990–1000

    Article  PubMed  Google Scholar 

  32. Marks R, Gebauer K, Shumack S et al. (2001) Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 44: 807–813

    Article  PubMed  Google Scholar 

  33. Marmur ES, Schmults CD, Goldberg DJ (2004) A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30: 264–271

    Article  PubMed  Google Scholar 

  34. Marnett LJ (1994) Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev 13: 303–308

    Article  PubMed  Google Scholar 

  35. Marshall J (1968) Treatment of solar keratoses with topically-applied cytostatic agents. Br J Dermatol 80: 540–542

    Article  PubMed  Google Scholar 

  36. Masferrer JL, Leahy KM, Koki AT et al. (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306–1311

    PubMed  Google Scholar 

  37. McEwan LE, Smith JG (1997) Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses. Australas J Dermatol 38: 187–189

    PubMed  Google Scholar 

  38. Morton C, Campbell S, Gupta G et al. (2006) Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 155: 1029–1036

    Article  PubMed  Google Scholar 

  39. Morton C, Horn M, Leman J et al. (2006) Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch Dermatol 142: 729–735

    Article  PubMed  Google Scholar 

  40. Morton CA (2004) Photodynamic therapy for nonmelanoma skin cancer--and more? Arch Dermatol 140: 116–120

    Article  PubMed  Google Scholar 

  41. Morton CA, Brown SB, Collins S et al. (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146: 552–567

    Article  PubMed  Google Scholar 

  42. Morton CA, Whitehurst C, McColl JH et al. (2001) Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 137: 319–324

    PubMed  Google Scholar 

  43. Morton CA, Whitehurst C, Moore JV, MacKie RM (2000) Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy. Br J Dermatol 143: 767–772

    Article  PubMed  Google Scholar 

  44. Newman N, Newman A, Moy LS et al. (1996) Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg 22: 455–460

    Article  PubMed  Google Scholar 

  45. Pariser DM, Lowe NJ, Stewart DM et al. (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48: 227–232

    Article  PubMed  Google Scholar 

  46. Pfister H, Ter Schegget J (1997) Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 15: 335–347

    Article  PubMed  Google Scholar 

  47. Piacquadio DJ, Chen DM, Farber HF et al. (2004) Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 140: 41–46

    Article  PubMed  Google Scholar 

  48. Rhodes LE, de Rie M, Enstrom Y et al. (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140: 17–23

    Article  PubMed  Google Scholar 

  49. Rivers JK, Arlette J, Shear N et al. (2002) Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 146: 94–100

    Article  PubMed  Google Scholar 

  50. Salim A, Leman JA, McColl JH et al. (2003) Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease. Br J Dermatol 148: 539–543

    Article  PubMed  Google Scholar 

  51. Sander CA, Pfeiffer C, Kligman AM, Plewig G (1997) Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 36: 236–238

    Article  PubMed  Google Scholar 

  52. Schon M, Bong AB, Drewniok C et al. (2003) Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 95: 1138–1149

    PubMed  Google Scholar 

  53. Shumack S, Robinson J, Kossard S et al. (2002) Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 138: 1165–1171

    Article  PubMed  Google Scholar 

  54. Smeets NW, Krekels GA, Ostertag JU et al. (2004) Surgical excision vs Mohs‘ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364: 1766–1772

    Article  PubMed  Google Scholar 

  55. Smith KJ, Germain M, Skelton H (2001) Squamous cell carcinoma in situ (Bowen’s disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 27: 561–564

    Article  PubMed  Google Scholar 

  56. Sterry W, Ruzicka T, Herrera E et al. (2002) Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 147: 1227–1236

    Article  PubMed  Google Scholar 

  57. Stockfleth E, Christophers E, Benninghoff B, Sterry W (2004) Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study. Arch Dermatol 140: 1542

    Article  Google Scholar 

  58. Szeimies RM, Karrer S, Radakovic-Fijan S et al. (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 47: 258–262

    Article  PubMed  Google Scholar 

  59. Thissen MR, Schroeter CA, Neumann HA (2000) Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 142: 338–339

    Article  PubMed  Google Scholar 

  60. Touma D, Yaar M, Whitehead S et al. (2004) A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 140: 33–40

    Article  PubMed  Google Scholar 

  61. Vinciullo C, Elliott T, Francis D et al. (2005) Photodynamic therapy with topical methyl aminolaevulinate for ‚difficult-to-treat‘ basal cell carcinoma. Br J Dermatol 152: 765–772

    Article  PubMed  Google Scholar 

  62. Wang I, Bendsoe N, Klinteberg CA et al. (2001) Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144: 832–840

    Article  PubMed  Google Scholar 

  63. Weiss J, Menter A, Hevia O et al. (2002) Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis 70: 22–29

    Google Scholar 

  64. Witheiler DD, Lawrence N, Cox SE et al. (1997) Long-term efficacy and safety of Jessner’s solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Dermatol Surg 23: 191–196

    Article  PubMed  Google Scholar 

  65. Wolf JE Jr, Taylor JR, Tschen E, Kang S (2001) Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 40: 709–713

    Article  PubMed  Google Scholar 

  66. Wollina U, Konrad H, Karamfilov T (2001) Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther 3: 63–66

    Article  PubMed  Google Scholar 

  67. Yuge S, Godoy DA, Melo MC et al. (2006) Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil. J Am Acad Dermatol 54: S218–219

    Article  PubMed  Google Scholar 

  68. Zeitouni NC, Oseroff AR, Shieh S (2003) Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 39: 1133–1136

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

  1. Hautklinik, Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Deutschland

    U.R. Hengge

Authors
  1. U.R. Hengge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U.R. Hengge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hengge, U. Lokale Therapie von Plattenepithelkarzinomen. Hautarzt 58, 412–418 (2007). https://doi.org/10.1007/s00105-007-1317-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-007-1317-x

Schlüsselwörter

Keywords

Search

Navigation